The global wound dressings market size was estimated to be USD 12.78 billion in 2023 and is expected to reach at USD 28.69 billion by 2034 with a CAGR of 7.63% during the forecast period 2024-2034. Increasing prevalence of chronic wounds such as venous leg ulcers, diabetic foot ulcers, pressure ulcers & surgical site wounds, growing geriatric population, surge in traumatic accidents, rising volume of surgical procedures, increasing government initiatives, growing awareness initiatives, and surge in launch of innovative wound dressing products are some of the key factors boosting the market growth.
Surge in launch of innovative wound dressing products is predicted to boost the market growth during the forecast period. Advanced wound dressings are required primarily for treating chronic wounds, surgical procedures, burn injuries, and trauma cases. These dressings encompass both traditional moist and active products, which are augmented with medicinal formulations to improve their healing capabilities. Hence, the rising number of surgical procedures, burn injuries, and trauma cases is expected to drive the demand for advanced wound dressings. For instance, In October 2022, RedDress, a privately owned global medical device company headquartered in the United States and Israel, has unveiled the ActiGraft+ system, which represents the next iteration of their wound management system. ActiGraft+ is FDA-approved and serves as an improved version of the initial technology, intended to reduce coagulation time and generate a superior-quality externally applied blood clot.
By product, advanced dressing was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the rising prevalence of obesity & venous leg ulcers, the availability of a wide range of products, increasing research & development activities to advance the products, growing geriatric population, surge in number of sports injuries, and rising launch of new products. For instance, in January 2023, Convatec is excited to introduce ConvaFoam to the United States, a series of advanced foam dressings specifically created to cater to the requirements of healthcare professionals and their patients. ConvaFoam can be applied to a wide range of wound types, regardless of their stage in the healing process, making it the straightforward choice for wound care and skin safeguarding. Additionally, traditional dressing is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of burn cases, increasing prevalence of accident injuries, and rising launch of new products.
By application, chronic wounds was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the increasing prevalence of chronic diseases including diabetes & diabetic foot ulcers, growing geriatric population, and surge in research & development activities. For instance, in June 2023, JeNaCell, which is now a part of Evonik, has introduced the wound dressing called epicite balance to the German market. This dressing is specifically designed and fine-tuned for managing chronic wounds that have a low to moderate level of fluid discharge, including conditions like venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue injuries. epicite balance is available in three varying sizes and will be supplied to hospitals and homecare centers through the distributor Coopmed ApS. Additionally, acute wounds is predicted to grow at fastest CAGR during the forecast period owing to the growing number of surgical wounds, rising surgical site infections, and surge in prevalence of traumatic accidents.
By end-user, hospitals was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the increasing number of surgical procedures conducted within hospitals, growing number of hospitals & hospitalization, and rising research & development activities. For instance, in July 2022, MolecuLight Inc., a company specializing in point-of-care fluorescence imaging for identifying wounds with increased bacterial levels, has revealed the results of an impartial, randomized controlled trial published in Diabetes Care. According to the publication, patients with diabetic foot ulcers who utilized the MolecuLight i:X device to detect high bacterial burden in wounds experienced wound healing rates that were double those of individuals who solely relied on standard-of-care over a 12-week period, with an increase of 204%. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the rising preference for home healthcare setting by geriatric population & bariatric population and growing focus on development of advanced products.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing healthcare infrastructure, rising number of surgeries, increasing prevalence of diabetic populations, and surge in mergers & acquisitions between market players. For instance, in March 2022, Convatec Group has acquired Triad Life Sciences Inc, a company based in Tennessee. The existing portfolio and product pipeline of Triad will now become a part of Convatec's Advanced Wound Care (AWC) division and is expected to be referred to as Convatec Advanced Tissue Technologies. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of diabetic population who are more prone towards diabetic foot ulcers, surge in number of accident injuries, rising government efforts, growing awareness initiatives by market players, and increasing new product launches. For instance, in October 2022, Healthium Medtech, headquartered in Bengaluru, has introduced a new range of wound dressings called Theruptor Novo, designed for the treatment of chronic wounds such as diabetic foot ulcers and leg ulcers. This launch enhances Healthium's current lineup of patented products within the advanced wound dressing category.
Alginate Dressing
Foam Dressing
Hydrogel Dressing
Collagen Dressing
Hydrocolloid Dressing
Others
Silver Dressing
Biomaterials
Surge in launch of innovative wound dressing products is predicted to boost the market growth during the forecast period. Advanced wound dressings are required primarily for treating chronic wounds, surgical procedures, burn injuries, and trauma cases. These dressings encompass both traditional moist and active products, which are augmented with medicinal formulations to improve their healing capabilities. Hence, the rising number of surgical procedures, burn injuries, and trauma cases is expected to drive the demand for advanced wound dressings. For instance, In October 2022, RedDress, a privately owned global medical device company headquartered in the United States and Israel, has unveiled the ActiGraft+ system, which represents the next iteration of their wound management system. ActiGraft+ is FDA-approved and serves as an improved version of the initial technology, intended to reduce coagulation time and generate a superior-quality externally applied blood clot.
By product, advanced dressing was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the rising prevalence of obesity & venous leg ulcers, the availability of a wide range of products, increasing research & development activities to advance the products, growing geriatric population, surge in number of sports injuries, and rising launch of new products. For instance, in January 2023, Convatec is excited to introduce ConvaFoam to the United States, a series of advanced foam dressings specifically created to cater to the requirements of healthcare professionals and their patients. ConvaFoam can be applied to a wide range of wound types, regardless of their stage in the healing process, making it the straightforward choice for wound care and skin safeguarding. Additionally, traditional dressing is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of burn cases, increasing prevalence of accident injuries, and rising launch of new products.
By application, chronic wounds was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the increasing prevalence of chronic diseases including diabetes & diabetic foot ulcers, growing geriatric population, and surge in research & development activities. For instance, in June 2023, JeNaCell, which is now a part of Evonik, has introduced the wound dressing called epicite balance to the German market. This dressing is specifically designed and fine-tuned for managing chronic wounds that have a low to moderate level of fluid discharge, including conditions like venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue injuries. epicite balance is available in three varying sizes and will be supplied to hospitals and homecare centers through the distributor Coopmed ApS. Additionally, acute wounds is predicted to grow at fastest CAGR during the forecast period owing to the growing number of surgical wounds, rising surgical site infections, and surge in prevalence of traumatic accidents.
By end-user, hospitals was the highest revenue-grossing segment in the global wound dressings market in 2023 owing to the increasing number of surgical procedures conducted within hospitals, growing number of hospitals & hospitalization, and rising research & development activities. For instance, in July 2022, MolecuLight Inc., a company specializing in point-of-care fluorescence imaging for identifying wounds with increased bacterial levels, has revealed the results of an impartial, randomized controlled trial published in Diabetes Care. According to the publication, patients with diabetic foot ulcers who utilized the MolecuLight i:X device to detect high bacterial burden in wounds experienced wound healing rates that were double those of individuals who solely relied on standard-of-care over a 12-week period, with an increase of 204%. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the rising preference for home healthcare setting by geriatric population & bariatric population and growing focus on development of advanced products.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing healthcare infrastructure, rising number of surgeries, increasing prevalence of diabetic populations, and surge in mergers & acquisitions between market players. For instance, in March 2022, Convatec Group has acquired Triad Life Sciences Inc, a company based in Tennessee. The existing portfolio and product pipeline of Triad will now become a part of Convatec's Advanced Wound Care (AWC) division and is expected to be referred to as Convatec Advanced Tissue Technologies. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of diabetic population who are more prone towards diabetic foot ulcers, surge in number of accident injuries, rising government efforts, growing awareness initiatives by market players, and increasing new product launches. For instance, in October 2022, Healthium Medtech, headquartered in Bengaluru, has introduced a new range of wound dressings called Theruptor Novo, designed for the treatment of chronic wounds such as diabetic foot ulcers and leg ulcers. This launch enhances Healthium's current lineup of patented products within the advanced wound dressing category.
Segmentation: Wound Dressings Market Report 2023 - 2034
Wound Dressings Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Traditional Dressing
- Bandages
- Tape
- Gauze
- Cotton
- Others
- Advanced Dressing
- Moist Dressing
Alginate Dressing
Foam Dressing
Hydrogel Dressing
Collagen Dressing
Hydrocolloid Dressing
Others
- Antimicrobial Dressing
Silver Dressing
- Active Dressing
Biomaterials
Wound Dressings Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Others
- Acute Wounds
- Burns
- Surgical & Traumatic Wounds
Wound Dressings Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Healthcare
- Hospitals
- Research & Manufacturing
- Outpatient Facilities
Wound Dressings Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Wound Dressings Market: Product Estimates & Trend Analysis
8. Wound Dressings Market: Application Estimates & Trend Analysis
9. Wound Dressings Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Wound Dressings Market
12. Europe Global Wound Dressings Market
13. Asia Pacific Global Wound Dressings Market
14. Latin America Global Wound Dressings Market
15. MEA Global Wound Dressings Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Ethicon (Johnson & Johnson)
- Smith+Nephew
- Convatec Group PLC
- Coloplast Corp.
- Medline Industries Inc.
- 3M
- Brightwake Ltd.
- Integra LifeSciences
- URGO
- PAUL HARTMANN AG
- Mölnlycke Health Care AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 12.78 Billion |
| Forecasted Market Value ( USD | $ 28.69 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
